Cargando…
Pseudophakic cystoid macular edema prevention and risk factors; prospective study with adjunctive once daily topical nepafenac 0.3% versus placebo
BACKGROUND: Define the effectiveness of a topical non-steroidal anti-inflammatory drug (NSAID) added to topical steroid use after uncomplicated phacoemulsification for the prevention of pseudophakic cystoid macular edema (PCME) using a prospective, randomized, double-masked, placebo-controlled clini...
Autores principales: | McCafferty, Sean, Harris, April, Kew, Corin, Kassm, Tala, Lane, Lisa, Levine, Jason, Raven, Meisha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5319126/ https://www.ncbi.nlm.nih.gov/pubmed/28219426 http://dx.doi.org/10.1186/s12886-017-0405-7 |
Ejemplares similares
-
Clinical Course of Pseudophakic Cystoid Macular Edema Treated with Nepafenac
por: Aaronson, Alexander, et al.
Publicado: (2020) -
Factors predicting response of pseudophakic cystoid macular edema to topical steroids and nepafenac
por: Sengupta, Sabyasachi, et al.
Publicado: (2018) -
Efficacy of Topical Nepafenac 0.3% in the Management of Postoperative Cystoid Macular Edema
por: Giarmoukakis, Athanassios K, et al.
Publicado: (2020) -
Pseudophakic cystoid macular edema: update 2016
por: Grzybowski, Andrzej, et al.
Publicado: (2016) -
Pathophysiology of Transient Corneal Edema and Pseudophakic Cystoid Macular Edema
por: Han, Sang Beom, et al.
Publicado: (2015)